What does GYN&FORM do?

GYN&FORM is a specialist medical practice in Esneux. Private Limited, started on 13 January 2022, 1 establishment.

What is the address of GYN&FORM?

The registered office of GYN&FORM is located at Rue de Limoges 112, 4130 Esneux.

Is GYN&FORM still active?

Yes. According to the CBE (31 October 2026) GYN&FORM is active, legal situation “Normale toestand”, started on 13 January 2022.

Is GYN&FORM registered on Peppol?

Yes, GYN&FORM is registered on the Peppol network with ID 0208:0780434086.

What is the enterprise number of GYN&FORM?

The enterprise number of GYN&FORM is BE0780434086.

When was GYN&FORM founded?

GYN&FORM was founded on 13 January 2022.

Who are the directors of GYN&FORM?

According to the 2025 annual accounts, the directors of GYN&FORM are: Anne AGNESSEN, Sarah PARTOUNE.

Is GYN&FORM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 January 2022; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did GYN&FORM make in 2025?

GYN&FORM posted a profit after taxes of € 99,386 in financial year 2025.

What is the revenue of GYN&FORM?

As a small company, GYN&FORM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 165,240.

GYN&FORM (Private Limited) - Esneux - BE0780434086

Dossier GYN&FORM, printed on 1 November 2026 from databakkes.be/en/0780434086/gyn-form. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GYN&FORM from Esneux, company number BE0780434086, closed financial year 2025 with a result of € 99,386 after tax. For that financial year GYN&FORM recorded a gross margin of € 165,240 and equity of € 192,718. Compared with financial year 2024, the result moved from € 33,946 to € 99,386. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 192,718

▲ 105% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 99,386

▲ 193% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 202,373

▲ 135% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

1 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 7,233

▼ 41% vs 2024

€ 5,077 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 514

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,928

▲ 4% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 54,744 Gross margin 2022: € 54,744 First fiscal year in the series	€ 31,009 Gross margin 2023: € 31,009 ▼ 43% vs 2022 (€ 54,744) Unfavourable step	€ 90,922 Gross margin 2024: € 90,922 ▲ 193% vs 2023 (€ 31,009) Favourable step	€ 165,240 Gross margin 2025: € 165,240 ▲ 82% vs 2024 (€ 90,922) Favourable step	▲ 82%
Profit after taxes	€ 41,400 Profit after taxes 2022: € 41,400 First fiscal year in the series	€ 17,977 Profit after taxes 2023: € 17,977 ▼ 57% vs 2022 (€ 41,400) Unfavourable step	€ 33,946 Profit after taxes 2024: € 33,946 ▲ 89% vs 2023 (€ 17,977) Favourable step	€ 99,386 Profit after taxes 2025: € 99,386 ▲ 193% vs 2024 (€ 33,946) Favourable step	▲ 193%
Equity	€ 43,900 Equity 2022: € 43,900 First fiscal year in the series	€ 61,077 Equity 2023: € 61,077 ▲ 39% vs 2022 (€ 43,900) Favourable step	€ 94,164 Equity 2024: € 94,164 ▲ 54% vs 2023 (€ 61,077) Favourable step	€ 192,718 Equity 2025: € 192,718 ▲ 105% vs 2024 (€ 94,164) Favourable step	▲ 105%
Total debts	€ 62,038 Total debts 2022: € 62,038 First fiscal year in the series	€ 27,891 Total debts 2023: € 27,891 ▼ 55% vs 2022 (€ 62,038) Favourable step	€ 36,171 Total debts 2024: € 36,171 ▲ 30% vs 2023 (€ 27,891) Unfavourable step	€ 44,448 Total debts 2025: € 44,448 ▲ 23% vs 2024 (€ 36,171) Unfavourable step	▲ 23%
Cash	€ 25,764 Cash 2022: € 25,764 First fiscal year in the series	€ 44,239 Cash 2023: € 44,239 ▲ 72% vs 2022 (€ 25,764) Favourable step	€ 86,292 Cash 2024: € 86,292 ▲ 95% vs 2023 (€ 44,239) Favourable step	€ 202,373 Cash 2025: € 202,373 ▲ 135% vs 2024 (€ 86,292) Favourable step	▲ 135%
Retained profit	€ 41,400 Retained profit 2022: € 41,400 First fiscal year in the series	€ 58,577 Retained profit 2023: € 58,577 ▲ 41% vs 2022 (€ 41,400) Favourable step	€ 91,664 Retained profit 2024: € 91,664 ▲ 56% vs 2023 (€ 58,577) Favourable step	€ 190,218 Retained profit 2025: € 190,218 ▲ 108% vs 2024 (€ 91,664) Favourable step	▲ 108%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 0) Unchanged	€ 859 Dividend 2024: € 859 ▲ 7% vs 2023 (€ 800) Unchanged	€ 833 Dividend 2025: € 833 ▼ 3% vs 2024 (€ 859) Unchanged	▼ 3%
Bank debt	€ 21,656 Bank debt 2022: € 21,656 First fiscal year in the series	€ 16,978 Bank debt 2023: € 16,978 ▼ 22% vs 2022 (€ 21,656) Favourable step	€ 12,173 Bank debt 2024: € 12,173 ▼ 28% vs 2023 (€ 16,978) Favourable step	€ 7,233 Bank debt 2025: € 7,233 ▼ 41% vs 2024 (€ 12,173) Favourable step	▼ 41%
Balance sheet total	€ 105,938 Balance sheet total 2022: € 105,938 First fiscal year in the series	€ 88,968 Balance sheet total 2023: € 88,968 ▼ 16% vs 2022 (€ 105,938) Unchanged	€ 160,735 Balance sheet total 2024: € 160,735 ▲ 81% vs 2023 (€ 88,968) Unchanged	€ 268,551 Balance sheet total 2025: € 268,551 ▲ 67% vs 2024 (€ 160,735) Unchanged	▲ 67%

Key figures of GYN&FORM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GYN&FORM?

What happened at GYN&FORM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 99,386 (▲ 193% vs 2024). filed late Source: NBB ↗
2024 Anne AGNESSEN became a director. NBB
Jan 13, 2022 New establishment in Esneux. KBO
Jan 13, 2022 Start of the company according to the CBE. KBO

In short

From € 41,400 profit in 2022 to € 99,386 profit in 2025.

Paid € 65,884 in corporate taxes since 2022.

Best year ever: 2025, with € 99,386 profit.

Paid out € 2,492 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Anne AGNESSEN Sarah PARTOUNE

GYN&FORM

Behind GYN&FORM are Anne AGNESSEN and Sarah PARTOUNE.

Directors

According to the 2025 annual accounts

Anne AGNESSEN

Director

since 2024

Sarah PARTOUNE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Limoges 112

4130 Esneux

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0780.434.086
VAT number: BE 0780.434.086
Registered office: Rue de Limoges 112, 4130 Esneux
Names & denominations: GYN&FORM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 January 2022
Peppol: Active · Active since 11 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗